JNJ vs CVS
By Alex · Tickerpine
Johnson & Johnson vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CVS |
|---|---|---|
| Price | $263.81 | $93.47 |
| Market cap | $635.07B | $119.55B |
| P/E ratio | 40.0 | 24.6 |
| ROE | 20.02% | 6.21% |
| Profit margin | 16.20% | 1.18% |
| Revenue growth | 5.90% | 7.10% |
| Dividend yield | 2.03% | 2.85% |
| Beta | 0.21 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CVS in plain English
- JNJ is the bigger company — about 5.3× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.6 vs 40.0).
- JNJ earns a higher return on equity (20% vs 6%).
- CVS is growing revenue faster (7% vs 6%).
- CVS has the higher dividend yield (2.85% vs 2.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.